Grup d’Investigació Oncològica, Translacional, Epidemiològica i Clínica (GIOTEC)

ONCOLOGÍA
OBJECTIUS

• Investigación clínica en las principales localizaciones tumorales mediante ensayos Fase I, Fase II, Fase III y estudios de vida real (Real World Studies), con el objetivo de ofrecer a los pacientes oncológicos la posibilidad de ser tratados con nuevas moléculas anticipándonos a su comercialización.

• Estudios multiómicos traslacionales (genómica, epigenómica, transcriptómica y metabolómica) a partir de biofluidos de pacientes oncológicos, con objetivos diagnósticos, pronósticos, y predictivos de respuesta a tratamientos antineoplásicos.

• Investigación en epidemiología del cáncer tanto des del punto de vista descriptivo como analítico a partir de los resultados del Registro Poblacional de Cáncer de Tarragona, en colaboración con REDECAN (Red Española de Registros de Cáncer).

• Combinación interdisciplinar de estudios epidemiológicos, clínicos y traslacionales.

 

RESPONSABLES
  • Dr. Joan Lluís Borràs Balada

  • Dr. Josep Gumà Padró

  • Líneas de investigación
  • Estructuras y tesis
  • TRANSFERENCIA
  • Miembros del grupo
  • Redes
  • Publicaciones
  • Proyectos
  • Contacto

Investigación clínica
Responsable: Dr. Joan Borràs Balada
Coordinadora de estudios: Berta Caballé Gutiérrez

a.  Ensayos clínicos en fase II e III, y Real-World Studies las principales localizaciones tumorales.
b.  Ensayos clínicos tipos “Basket Trial” para tumores con determinadas mutaciones genéticas.
c.  Estudios de factores pronósticos y predictivos de respuesta.

 

Investigación epidemiológica
Responsable: Dr. Jaume Galceran

a.  En el campo de la investigación epidemiológica, se centra en estudios de base  poblacional relacionados con el Registro de Cáncer de Tarragona.
b.  En el campo de la investigación en prevención, se centra en estudios relativos a las cribas de cáncer.

 

Investigación básica y traslacional (Responsable Dr. Josep Gumà)
El grupo de investigación se centra en el estudio genómico y metabólico del cáncer, incluyendo la identificación de mutaciones hereditarias y la investigación de biomarcadores de respuesta al tratamiento. También investigan el papel de la microbiota intestinal en la respuesta a inmunoterapia y su uso en el diagnóstico precoz del cáncer.

  1. Cáncer de mama y ovario hereditario (CMOH)

Responsable: Dra. Marta Rodríguez

  1. Metabolómica avanzada y cáncer

Responsable: Dra. Raquel Cumeras

  1. Microbioma y cáncer

Responsable: Dr. Josep Gumà

  1. Oncología de precisión

Responsable: Dr. Francesc Riu

 

Investigación en psicooncologia
Responsable: Dra. Agustina Sirgo

Estudiar el impacto de la enfermedad oncológica. A nivel social, el estudio de los beneficios del grupo de autoayuda de mujeres con cáncer de mama.

    Estructuras

  • Unidad de Investigación Clínica Oncológica (URCO): estructura en la que se llevan a cabo los Ensayos Clínicos del Instituto de Oncología de la Cataluña Sur. Cuenta con coordinadores de estudios, bioinformáticos y administrativos.

    El coordinador del grupo es el Dr. Joan Borràs Balada.

  • Unidad de Patología Molecular Oncológica (UPMO): estructura creada a partir de la colaboración de los servicios de Oncología y de Anatomía Patológica del Hospital Universitari Sant Joan de Reus. Participan los médicos del Servicio de Oncología Médica, los biólogos de la Unidad de Cáncer Hereditario y los médicos y biotecnólogos del Servicio de Anatomía

    Los coordinadores de esta estructura son el Dr. Josep Gumà Padró y el Dr. Francesc Riu Ferrando.

  • Servicio de Epidemiología y Prevención del Cáncer (SEPC): servicio del Hospital Universitario Sant Joan de Reus dedicado a la investigación epidemiológica y al registro poblacional del cáncer.

    El coordinador del grupo es el Dr. Jaume Galceran Padrós.

     

     

     

    Tesis

  • Impact of fatty acid metabolism in breast cancer peritumoral tissue. Clinical and pathogenic aspects.
    Author: Jose Adriá Cebrián
    Directors: Dr. Josep Gumà Padró, Dr. Sandra Guaita Esteruelas
    Doctoral Program at Universitat Rovira i Virgili: Biomedicine
    Defense Date: 2022, May 6.

    Grade: Excellent Cum Laude (maximum grade in Spanish University system)
    Current job: Medial writer at Novarti

  • Axillary salvage after neoadjuvant chemotherapy in cN1 breast cancer patients: combined sentinel node-axillary ROLL technique
    Author: Jordi Fuentes Manuel
    Director: Josep Gumà Padró
    Doctoral Program at Universitat Rovira i Virgili: Biomedicine
    Defense Date: 2022, July 8
    Grade: Excel·lent Cum Laude (maximum grade in Spanish University system)

    Current job: Head of Nuclear medicine department of Hospital Universitari Sant Joan de Reus

  • Application of omic techniques to improve the diagnosis of hereditary breast and ovarian cancer syndrome
    Author: Marta Rodríguez Balada.
    Directors: Lourdes Martorell, Dr. Josep Gumà Padró
    Doctoral Program at Universitat Rovira i Virgili: Biomedicine
    Defense Date: 2020, November 13
    Grade: Excel·lent Cum Laude (maximum grade in Spanish University system)

    Current job: Head of a GIOTEC’s research line. Head of the genetic counseling unit of Institut d’Oncologia de la Catalunya Sud

  • Usefulness of cognition-guided biopsies by MRI to improve the detection of prostate cancer
    Author: José García Bennett
    Directors: Joan Carles Vilanova Busquets, Dr. Josep Gumà Padró
    Doctoral Program at Universitat Rovira i Virgili: Biomedicine
    Defense Date: 2018, March 12
    Excel·lent Cum Laude (maximum grade in Spanish University system)

    Current job: Radiologist at Hospital Univ. de Bellvitge.

  • Epidemiología de las neoplasias malignas de ovario en Tarragona, 1980-2005.
    Author: Antonio Llueca Abella.
    Directors: Joan Lluís Borràs Balada, Dr. Josep Gumà Padró.
    Doctoral Program at Universitat Rovira i Virgili: Biomedicine
    Defense Date: 2012
    Apt Cum Laude

  • Epidemiologia de les neoplàsies limfoides a les comarques de Tarragona, 1980-2004
    Author: Josep Gumà Padró
    Director: Joan Lluís Borràs Balada
    Doctoral Program at Universitat Rovira i Virgili: Biomedicine
    Defense Date: 2010

    Guias de práctica clínica

  • Propietat industrial i intel·lectual Software

    Romera P, Villalba H, Llambrich M, Cumeras R. “Human biofluids composition: saliva and breath as life fluids” registered at SafeCreative w/ reference 2306124568135 (June 16, 2023).

    Projectes d’innovació

    Recur Detect: Early detection of recurrence and metastasis Test.

    PI: Raquel Cumeras.

    Team member: Maria Llambrich, Núria Amigó, Josep Gumà.

    Duration: 2023-2023.

    Funding entity: Intellectual Property CALL2023.

  • Gumà J, et al., SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma. Clin Transl Oncol. 2023; In Press.

  • Aldea A, Arriola E, Borràs JM, Bosch J, Carreras MJ, Conde D, Córdoba JF, Felip E, Fontanals S, Guarga L, Majem M, Mangues I, Martínez J, Moreno E, Nadal E, Peralta S, Rodríguez MC, Serrano G, Vilà L, Viñolas N. Coordination: Gasol M, Gay D, Guarga L, Martínez J, Puig G, Sancho A. Management: Pontes C, Vallano A. Programa d’harmonització farmacoterapèutica. Pautes per a l’harmonització del tractament farmacològic del càncer de pulmó no microcític metastàtic. Versió 2.0. Barcelona: Servei Català de la Salut. Departament de Salut. Generalitat de Catalunya; 2022.

  • Aparicio J, Terrasa J, Durán I, Germà-Lluch JR, Gironés R, González-Billalabeitia E, Gumà J, Maroto P, Pinto A, García-Del-Muro X. SEOM clinical guidelines for the management of germ cell testicular cancer (2016). Clin Transl Oncol. 2016 Dec;18(12):1187-1196. DOI: 10.1007/s12094-016-1566-1 . Epub 2016 Nov 4. PMID: 27815687; PMCID: PMC5138244.

  • Rueda Domínguez A, Alfaro Lizaso J, de la Cruz Merino L, Gumá i Padró J, Quero Blanco C, Gómez Codina J, Llanos Muñoz M, Martinez Banaclocha N, Rodriguez Abreu D, Provencio Pulla M. SEOM clinical guidelines for the treatment of Hodgkin’s lymphoma. Clin Transl Oncol. 2015 Dec;17(12):1005-13. DOI: 10.1007/s12094-015-1429-1 . Epub 2015 Oct 26. PMID: 26497354; PMCID: PMC4689754.

  • Provencio Pulla M, Alfaro Lizaso J, de la Cruz Merino L, Gumá i Padró J, Quero Blanco C, Gómez Codina J, Llanos Muñoz M, Martinez Banaclocha N, Rodriguez Abreu D, Rueda Domínguez A. SEOM clinical guidelines for the treatment of follicular non-Hodgkin’s lymphoma. Clin Transl Oncol. 2015 Dec;17(12):1014-9. DOI: 10.1007/s12094-015-1437-1 . Epub 2015 Nov 19. PMID: 26586117; PMCID: PMC4689757.

Responsables de grupo: Joan Lluís Borràs Balada, Josep Gumà Padró

Equipo de investigación: Kepa Amillano Parraga, Inés María Cabezas Montero, Francisca Martínez Madueño, Cristina Martí Blanco, Sergio Peralta Muñoz, Mireia Melé Olivé, Cinta Albacar Miró, Maria Masvidal Hernández, María José Miranda Pallarés, Jana Repkovà, David Ricardo Bottaro Parra, Raquel Cumeras Olmeda, Lola Delamo Palomares, Marc Grifoll Escoda, Cristina Miracle Huguet, Alberto Ameijide Sánchez, Xavier Cardó Moreno, Maria Carulla Areste, Sara Fernández Castillejo, Jaume Josep Maria Galceran Padrós, Sandra Merino Varela, Dulcenombre Maria Rodríguez Mesa, Marta Rodríguez Balada, Bàrbara Roig Bourgine, Beatriz Rubio Cantavella, Belén Ruiz Aguado, Francina Saladié Roiget, Sara Serrano Solares, Agustina Sirgo Rodríguez, Anna Vidal Rodríguez, Francisco Pedro Riu Ferrando, David Parada Domínguez, Karla Beatriz Peña González, Clara Beatriz Lucía Gozálvez, Jàmnica Bigorra Román, Claudia Pla González, Xavier Collado Castro, Alba Cochs Sarobe, Alexandra Cabré Pedrosa, Araceli Jiménez López, Berta Caballé Gutiérrez, Maria Teresa Parejo Arrondo, Margarita Moreno Mancho, Mònica Salvat Casas, Montserrat Querol García, Maria Murphy Colomé, Pilar Cervelló Arán, Sheila García Samaniego, Rocío López Rubio, Alba Lucena Gaspar, Anna Feliu Prius, Ana María Jiménez Santamaria, Ana Vidaller Ramón, Anna Maria Bonada Sanjaume, Arnau Guillemat Novo, Berta Mas Oliver, Cecília González Gómez-Navarro, Maria Dolors Salsench Boronat, Fabiola Medina Barajas, Immaculada Concepció Grau Farrús, Jacqueline Cimerman, Jordi Civit Oró, JULIA SERRA OLTRA, Laia Fortuny Parull, Laura Costa Claret, Laura Quintana Berto, Maria Vidal Escudé, Ona Pallisé Subirats, Salvador Martínez Soriano, Sandra Mateu Riba, Carlos Rodríguez, Koenraad Van Landuyt

  • El Registro de Cáncer de Tarragona es miembro de la Red Española de Registros de Cáncer (REDECAN). Asimismo, varios miembros del Registro de Cáncer de Tarragona realizaron labores en varias líneas de trabajo de esta red. Desde el año 2017 el Dr. Jaume Galceran es el presidente de esta red.

  • El Registro de Cáncer de Tarragona es miembro de la Red Europea de Registros de Cáncer (European Network of Cancer Registries –ENCR-) y de la Asociación Internacional de Registros de Cáncer (International Association of Cancer Registries –IACR-).

  • El Dr. Jaume Galceran es miembro del Steering Committee del Groupe pour l’Epidémiologie et la Grabación du Cancer dans las Pays de Langue Latine (GRELL).

  • La Dra. Raquel Cumeras co-lidera un grupo de trabajo de la Metabolomics Quality Assurance and Quality Control Consortium (mQACC)

  • Participación de miembros del grupo en los grupos cooperativos oncológicos:

    • GECP: Grupo Español de Investigación en Cáncer de Pulmón.
    • Grupo GEICAM de Investigación en Cáncer de Mama.
    • GEICO: Grupo Español de Investigación en Cáncer de Ovario.
    • GEINO: Grupo Español de Investigación en Neurooncología.
    • GEIS: Grupo Español de Investigación en Sarcomas.
    • GEM: Grupo Español Multidisciplinar de Melanoma.
    • GEMCAD: Grupo Español Multidisciplinar en Cáncer Digestivo.
    • GETICA: Grupo Español de Terapias Inmuno-Bioloógicas en Cáncer.
    • GETNE: Grupo Español de Tumores Neuroendocrinos y Endocrinos.
    • GG: Grupo Germinal Oncológico.
    • GOTEL: Grupo Oncológico para el Tratamiento de las Enfermedades Linfoides.
    • SOGUG: Grupo Español de Oncología Genitourinaria.
    • SOLTI
    • TTCC: Grupo Español de Tratamiento de Tumores de Cabeza y Cuello.
    • TTD: Grupo Español de Tratamiento de los Tumores Digestivos.
  • Participación en redes de innovación:

  • Participación de miembros del grupo en consorcios:

    Surrogate-matrix calibration for quantitative GC-IMS headspace analysis of urine.

    de la Cruz GG, Duran-Fort T, Fernandez L, Morago P, Rengel CJ, Gumà J, Marco S, Pardo A. 01/02/2027

    ERG expression is not predictive of outcome in patients with intermediate- and high-risk localized prostate cancer treated with combined androgen blockade and radiotherapy

    Henriquez, I, Malave, B, Benitez-Gabella, G, Parada, D, Canela, M, García-Pablo, R, Benavides, R, Rius, F, Arenas, M. 01/02/2026

    Incidence and Survival of Cutaneous Squamous Cell Carcinoma: A Spanish Multicenter Population-Based Study.

    Fernández-Martínez NF, Redondo-Sánchez D, Ameijide A, Carulla M, Rubió-Casadevall J, Marcos-Gragera R, Guevara M, Gasque A, García-Doval I, Arias-Santiago S, Galceran J, Sánchez MJ. 01/01/2026

    Survival trends and cure rates of hematological neoplasms in the Spanish pediatric population.

    Trallero J, Romaguera A, Ameijide A, Cañete A, Pardo E, Alfonso P, Jeghalef-El-Karoui N, De-La-Cruz M, Onaindia-Agundez A, Sanvisens A, Redondo-Sánchez D, Perucha J, Ruiz-Armengol P, Chirlaque MD, Guevara M, Gutiérrez P, Pla C, Merino-Perera S, Garrido-Martín M, Vizcaino-Batlles A, Lopez-de-Munain A, Marcos-Gragera R. 01/01/2026

    Improved Chromatographic Alignment of GC-IMS Data Using Spectral Information.

    Fernández L, Guedes de la Cruz G, Caballero E, Martín-López E, Vidal A, Alonso-Valdesueiro J, Gumà J, Cumeras R, Pardo A, Marco S. 21/10/2026

    The silence of the labs: Ethical oversight in metabolomics research.

    Badia J, Llambrich M, López-Rubio R, Saggion H, Cumeras R. 07/10/2026

    METLUNG: plasma metabolomic profiling identifies metabolomic signatures associated with immunotherapy outcomes in non-small cell lung cancer.

    Lucía-Gozálvez C, Papandreou C, Badia J, Cumeras R, Peralta S, Martí C, Vidaller A, Quintana L, Martínez S, Gumà J. 25/09/2026

    Cancer Patients Mortality From Other Causes: A European Population-Based Study

    Gatta, G, Capocaccia, R, Rossi, S, Athanasiadou, M, Bennett, D, Dusek, L, Galceran, J, Hackl, M, Holleczek, B, Innos, K, Katalinic, A, Marcos-Gragera, R, Murray, D, Schaffar, R, Smits, S, Smailyte, G, Storm, H, Vener, C, Zagar, T, Bernasconi, A, Jooste, V, Botta, L. 14/09/2026

    Is cancer increasing in young adults in Spain? Incidence trends from the Spanish Network of Cancer Registries (REDECAN) (vol 244, 116883, 2026)

    Redondo-Sánchez, D, Petrova, D, Bigorra, J, Ameijide, A, Pérez-Esparza, BM, Palacios-Castaño, MI, Farreny, MM, López, MDC, Guevara, M, Carulla, M, Meléndez, PG, Perera, SM, Martin, MCG, Díaz, XNA, Batllés, AV, Muñoz, IM, Mendizabal, N, Onaindia, A, Trallero, J, González-Flores, E, Galceran, J, Sánchez, MJ. 09/09/2026

    Hepatic immune microenvironment dynamics in severe obesity and post-bariatric surgery: insights from immunohistochemical analysis

    Onoiu, AI, González-Serrano, S, Cambra-Cortés, V, Jiménez-Franco, A, Guilarte, C, Peña, KB, Riu, F, Camps, J, Joven, J, Parada, D. 03/09/2026

    Is cancer increasing in young adults in Spain? Incidence trends from the Spanish Network of Cancer Registries (REDECAN).

    Redondo-Sánchez D, Petrova D, Bigorra J, Ameijide A, Madrid Pérez-Esparza B, Palacios-Castaño MI, Muncunill Farreny M, Chirlaque López MD, Guevara M, Carulla M, Gutiérrez Meléndez P, Merino Perera S, Garrido Martín MC, Álvarez Díaz XN, Vizcaíno Batllés A, Martin Muñoz I, Mendizabal N, Onaindia A, Trallero J, González-Flores E, Galceran J, Sánchez MJ. 26/08/2026

    Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors.

    Haggstrom L, Lee YC, Barretina-Ginesta MP, Jaeger A, Woelber L, Woopen H, Rhind M, Frenel JS, Aanum A, Bischof K, Mongillo M, Brodsky AL, Ledermann J, Ghezelayagh TS, Boere I, Kaiser S, Maximiano C, Rosengarten O, Safra T, Pertejo A, Cecere S, Ray-Coquard I, Lheureux S, Glasspool R, Gil-Martin M, Tookman L, Kim SI, Mittelstadt S, Corbellas Aparicio M, Palacio I, Martin-Lorente C, Kristeleit R, de la Cueva H, Ottevanger N, Quindós Varela M, Yoshida H, Link T, Gaba L, Marquina G, Burdett N, Johannet P, Reichenbach J, Park-Simon TW, Klecker PH, González-Martín A, Marth C, Liebrich C, Dzotsenidze L, Heublein S, Kasherman L, Perez C, Masvidal M, Guillén Sentís P, de Gregorio N, Hemptenmacher F, Hilpert F, Sehouli J, Scott C, Tucker KM, Dong J, Fortuno C, Spurdle AB, Friedlander M. 01/08/2026

    Concordance analysis of non-invasive techniques for PIK3CA and ESR1 mutations in advanced HR+/HER2- breast cancer: the CANIPE study

    Costa, C, Lago-Lestón, RM, Rodríguez-Casanova, A, Curiel, T, Rodríguez, C, Abalo, A, Abuín, C, Palacios, P, Cueva, J, Carmona, M, Cortegoso, A, Morales, S, Gumà, J, Amillano, K, Flores, ML, Fernández, Y, Pérez, IF, Sobrado, IF, Cortés, MG, Pena, C, García-Mata, J, de Miera, AS, Díaz-Lagares, A, Muinelo-Romay, L, López-López, R. 31/07/2026

    Translation, cross-cultural adaptation and preliminary psychometric evaluation of the Victoria Respiratory Congestion Scale into Spanish

    Canal-Sotelo, J, Martin-Marco, A, Bottaro-Parra, D, Blasi-Martínez, R, Nitola-Mendoza, L, Oller-Bonache, A, Camí, C, Barallat-Gimeno, E. 09/07/2026

    The preventable burden of tobacco-attributable cancer incidence in Catalonia (Spain) in 2024: a Bayesian approach.

    Clèries R, Martínez J, Ameijide A, Trallero J, Sanvicens A, Torres I, Carulla M, Buxó M, Espinàs JA, Godoy P, Marcos-Gragera R, Galceran J, Borràs JM. 05/07/2026

    Volatilomic analysis of urine and breath for prostate cancer detection using complementary GC-MS and electronic nose platforms

    Gómez, JKC, Acevedo, CMD, Vásquez, CAC, Tarazona, JMC, Zavala, AR, Llambrich, ML, Cumeras, R, Llecha, JB. 01/07/2026

    The importance of social vulnerability and exclusion in cancer prognosis and survival: a scoping review.

    Moragas-Fernandez A, García-Pablo R, Canela-Capdevila M, Benavides-Villareal R, Benitez-Gabella G, Escuin-Troncho C, Arenas M, Gumà J. 29/06/2026

    Long-Term Survival and Risk of Second Malignant Neoplasms Among Childhood Cancer Patients in 16 Provinces of Spain.

    Galceran J, Ameijide A, Jeghalef N, Sánchez A, Guevara M, Bigorra J, Gutiérrez P, Boone ALD, Garrido M, Álvarez X, Vizcaíno A, Martín I, Onaindia A, Sanclemente S, Trallero J, Sánchez MJ, Palacios MI, Clèries R, Carulla M, On Behalf Of The Spanish Network Of Cancer Registries Redecan. 18/06/2026

    Use of population-based cancer registry data to evaluate organized breast cancer screening programmes in Europe by mode of detection: a scoping review.

    Kam W, Guillaume E, Rollet Q, Petrova D, Fernández-Martínez NF, van Herck K, Carulla M, Pla C, Saladié F, Miracle C, Zadnik V, Tomšic S, Cowppli-Bony A, Launoy G, Backes C. 10/06/2026

    Clinical and Molecular Evaluation of HER2-Low and HER2-Ultralow Breast Cancer in the Penelope-B Clinical Trial Cohort.

    Denkert C, Rachakonda S, Pehl A, Marmé F, Martin M, Karn T, Untch M, Bonnefoi H, Kim SB, Hirmas N, Bear H, Witkiewicz AK, Im SA, DeMichele A, Van’t Veer L, McCarthy N, Stiewe T, Jank P, Gelmon KA, García-Sáenz JA, Westhoff C, Kelly CM, Reimer T, Olivé MM, Knudsen ES, van Mackelenbergh M, Rojo F, Frickel N, Fasching PA, Teply-Szymanski J, Toi M, Rugo HS, Gnant M, Makris A, Felder B, Nekljudova V, Loibl S. 01/06/2026

    A chemotherapy-free, pathological response-adapted strategy using trastuzumab-pertuzumab and T-DM1 in HER2-positive early breast cancer: the PHERGain-2 study.

    Garrigós L, Ruiz-Borrego M, Pérez-García JM, Guerrero-Zotano A, Cortés-Salgado A, Kuemmel S, Colleoni M, Reboredo-Rendo C, Bermejo B, Blancas I, Gavila J, Fabi A, Morales C, Stradella A, Carañana V, Martínez-de Dueñas E, Albacar C, Ballesteros-Cidras O, Martrat G, Iacobucci S, Boix O, Berenguer-Molins P, Alcalá-López D, Cortés J, Llombart-Cussac A. 01/06/2026

    A European collaborative initiative to systematically map cancer risk by migration background: the Cancer RADAR project.

    Alberts CJ, Georges D, Bray F, Bordoni A, Aresté MC, Chirlaque López MD, Didkowska J, Galceran J, Van Herck K, Migliore E, Ortelli L, Richiardi L, Sánchez Gil A, Verdoodt F, Visser O, Wojciechowska U, Gini A, Man I, Rosso S, Baussano I. 30/05/2026

    Best Practices in GC-MS and GC × GC-MS-Based Metabolomics and Volatile Analyses: An International Survey.

    Giebelhaus RT, Herold M, Harynuk JJ, Alonso DE, Amer B, Broeckling CD, Charisiadis P, Cumeras R, de la Mata AP, Dunn W, Franchina FA, Gika H, Kirwan JA, Muti IH, Najdekr L, Pujos-Guillot E, Stefanuto PH, Steininger-Mairinger T, Thakker A, Fiehn O. 12/05/2026

    Incidence and survival of epithelial salivary glands cancer by tumor site and histology in Tarragona and Girona, Catalonia, Spain.

    Rubió-Casadevall J, Trallero J, Puigdemont M, Carulla M, Mangues J, Sanvisens A, Ameijide A, Romaguera A, Vila AV, Pla C, Marruecos J, Marcos-Gragera R, Galceran J. 25/04/2026

    Development of a Revised Clinical Guide to Multidimensional Needs Assessment in Palliative Care: MAP.

    Goni-Fuste B, Crespo I, García-Salanova A, Monforte-Royo C, Rodríguez-Prat A, Alonso A, Belar A, Bottaro D, Candelmi D, Cimerman J, Costas E, de Iriarte N, Garrillo J, González-Barboteo J, Jimeno M, Nabal Vicuña M, Noguera-Sánchez P, Rocafort J, Rodríguez D, Sala C, Serna J, Balaguer A, Julià-Torras J. 01/04/2026

    Breast cancer incidence, by stage at diagnosis, and mortality in 21 European countries in the era of mammography screening: an international population-based study.

    Cardoso R, Ola I, Jansen L, Hackl M, Ihle P, Francart J, Van Damme N, Valerianova Z, Atanasov T, Májek O, Ngo O, Innos K, Mägi M, Yonli SD, Woronoff AS, Tretarre B, Poncet F, Katalinic A, Walsh PM, Vincerževskiene I, Steponaviciene L, de Munck L, Siesling S, Johannesen TB, Hofvind S, Calisto R, Bento MJ, Alves da Costa F, Mayer A, Lourenço A, Žagar T, Tomšic S, Rodríguez-Barranco M, Sánchez MJ, Lopez de Munain Marques A, Marcos-Gragera R, Sanvisens A, Gil AS, Chirlaque Lopez MD, Galceran J, Saladié F, Sundquist K, Sundquist J, Persson MÅ, Blum M, Mousavi M, von Moos R, Sumkina O, Ryzhov A, Hoffmeister M, Brenner H. 01/03/2026

    Circulating tumor DNA (ctDNA) in human epidermal growth factor receptor 2-positive (HER2[+]) Early Breast Cancer (EBC): Translational analysis of PHERGain neoadjuvant tailored treatment study

    Llombart-Cussac, A, Pérez-García, J, Ruiz-Borrego, M, Stradella, A, Bermejo, B, Escrivá-de-Romaní, S, Reboredo, C, Ribelles, N, Cortés-Salgado, A, Albacar, C, Colleoni, M, Antonarelli, G, Notini, G, Gion, M, García-Mosquera, J, Sanz, L, Martínez-García, E, González-Alonso, P, Amaya-Garrido, A, Guerrero, J, Rodríguez-Morató, J, Mina, L, Martrat, G, Quintana, M, Riva, F, Dustin, D, Zhang, H, Mancino, M, Cortés, J. 17/02/2026

    Associations of the HER2DX Genomic Test with Biological and Pathologic Features in HER2-Positive Breast Cancer.

    Sanfeliu E, Martínez-Romero A, Marín-Aguilera M, Cobo S, González-Farré B, Hernandez-Illan E, Jares P, Puig-Butillé JA, Muñoz M, Gómez-Bravo R, Tapia M, Tebar C, Saura C, Escrivà-de-Romaní S, Soberino J, Cortés J, Morales S, Amillano K, Paré L, Villagrasa P, Buckingham W, Pardo F, Parker JS, Brasó-Maristany F, Ciruelos E, Sánchez-Bayona R, Martinez-Sáez O, Cejalvo JM, Prat A. 04/02/2026

    A Pilot Study Exploring Paraoxonase-1 Tissue Protein Expression and Circulating Levels in Bladder Cancer.

    Parada D, Onoiu AI, Iftimie S, Camps J, Riu F, Castro A, Joven J. 02/02/2026

    High leptin levels independent of body mass index are associated with inflammation and poorer treatment response in patients with diffuse large B-cell lymphoma.

    Hontecillas-Prieto L, García-Domínguez DJ, Jiménez-Cortegana C, Nogales-Fernández E, Palazón-Carrión N, García-Sancho AM, Ríos-Herranz E, Gumà-Padrò J, Provencio-Pulla M, Rueda-Domínguez A, de la Cruz-Merino L, Sánchez-Margalet V. 01/02/2026

    Metabolomic-driven prediction of the mutational status of healthy individuals with a family history of hereditary breast and ovarian cancer syndrome: the HRRmet study.

    Roig B, Fernández-Castillejo S, Gumà J, Badia J, Melé M, Salvat M, Querol M, Cumeras R, Rodríguez-Balada M. 31/01/2026

    Liposomal irinotecan in patients with HER2-negative breast cancer and brain metastases: The PHENOMENAL phase 2 study.

    Borrego MR, López-Bravo DP, Vila MM, Pérez-García JM, Fernández M, Tormo SB, García-Saenz JÁ, Lema L, Garau I, Cortez P, Torres AA, Conejo EA, Calvo I, Ferrer N, Blancas I, Amillano K, Santasusagna S, Benderra MA, Alcalá-López D, Antonarelli G, Sampayo-Cordero M, Llombart-Cussac A, Cortés J. 17/01/2026

    Towards Breast Tumor Aggressiveness Classification in Digital Mammograms Using Boundary-Aware Segmentation and Feature Analysis

    Khalid, A, Mursil, M, Okran, AM, Padro, JG, Pablo, CL, Puig, D, Rashwan, HA. 01/01/2026

    Circulating Lipid Profiles Indicate Incomplete Metabolic Recovery After Weight Loss, Suggesting the Need for Additional Interventions in Severe Obesity (vol 15, 1112, 2025)

    Onoiu, AI, Cambra-Cortés, V, Jiménez-Franco, A, Hernández-Aguilera, A, Parada, D, Riu, F, Zorzano, A, Camps, J, Joven, J. 25/12/2025

    SEOM-GOTEL clinical guidelines on diffuse large B-cell lymphoma (update 2025)

    Gumà, J, Palazón-Carrión, N, Rueda-Domínguez, A, Sequero, S, Calvo, V, García-Arroyo, R, Gómez-Codina, J, Llanos, M, Martínez-Banaclocha, N, Provencio, M. 01/12/2025

    The impact of cancer survivors' extra risk of noncancer mortality on net survival estimation.

    Botta L, Capocaccia R, Bernasconi A, Rossi S, Galceran J, Dal Maso L, Lepage C, Molinié F, Bouvier AM, Marcos-Gragera R, Vener C, Guevara M, Murray D, Ragusa R, Gatta G, Jooste V. 04/11/2025

    Trends in the incidence of brain cancer and the use of mobile phones: analysis of the Spanish Network of Cancer Registries (REDECAN)

    Galceran, J, Ameijide, A, Cañete, A, Peris-Bonet, R, de Munain, AL, Aizpurúa, A, de la Cruz, M, Sanvisens, A, Sánchez, MJ, Palacios, I, Franch, P, Sánchez, A, Guevara, M, Carulla, M, Gutiérrez, P, Sáez, I, Rodríguez, M, Alemán, A, Sabater, C. 01/11/2025

    Performance and safety of Femorally Inserted Central Catheters in oncological patients: A cases series analysis

    Arrondo, MTP, Jurado, BG, Escat, LB, Ortiz-Miluy, G, Farrús, ICG, Gumà, J. 07/10/2025

    Dysregulation of the FGF21-Adiponectin Axis in a Large Cohort of Patients with Severe Obesity and Liver Disease

    Castañé, H, Jiménez-Franco, A, Onoiu, AI, Cambra-Cortés, V, Hernández-Aguilera, A, Parada, D, Riu, F, Zorzano, A, Camps, J, Joven, J. 02/09/2025

    IMPROVING THE COLORECTAL CANCER SCREENING PROGRAM WITH A BACTERIAL SIGNATURE IN THE PROTOCOL

    Miracle, C, Villar, M, Pamplona, J, Alburquerque, MA, Albert, M, Rivera, M, Ameijide, A, Galceran, J. 01/09/2025

    Circulating Lipid Profiles Indicate Incomplete Metabolic Recovery After Weight Loss, Suggesting the Need for Additional Interventions in Severe Obesity

    Onoiu, AI, Cambra-Cortés, V, Jiménez-Franco, A, Hernández-Aguilera, A, Parada, D, Riu, F, Zorzano, A, Camps, J, Joven, J. 01/08/2025

    A population-based study of incidence trends of head and neck epithelial cancers in northeastern Spain, 1994-2018

    Rubio-Casadevall, J, Trallero, J, Calvo, C, Puigdemont, M, Carulla, M, Sanvisens, A, Ameijide, A, Vidal, A, Pla, C, Marruecos, J, Marcos-Gragera, R, Galceran, J. 01/08/2025

    Incidence trends of colorectal cancer in young adults in Spain

    Galceran, J. 29/07/2025

    Effect of consumption of anthocyanin-rich products on NMR lipoprotein subclasses and biomarkers in hypercholesterolemic subjects: a randomized controlled trial (the AppleCOR study)

    Pedret, A, Llauradó, E, Calderón-Pérez, L, Companys, J, Pla-Pagà, L, Salamanca, P, Sandoval-Ramírez, BA, Besora-Moreno, M, Catalán, U, Fernández-Castillejo, S, Ludwig, I, Macia, A, Rubió-Piqué, L, Sampson, M, Remaley, AT, Valls, RM, Motilva, MJ, Solà, R. 17/03/2025

    GcDUO: an open-source software for GC x GC-MS data analysis

    Llambrich, M, van der Kloet, FM, Sementé, L, Rodrigues, A, Samanipour, S, Stefanuto, PH, Westerhuis, JA, Cumeras, R, Brezmes, J. 04/03/2025

    Obesity and overweight in R/R DLBCL patients is associated with a better response to treatment of R2-GDP-GOTEL trial. Potential role of NK CD8 + cells and vitamin D.

    Hontecillas-Prieto L, García-Domínguez DJ, Jiménez-Cortegana C, Nogales-Fernández E, Palazón-Carrión N, García-Sancho AM, Ríos-Herranz E, Gumà-Padrò J, Provencio-Pulla M, Rueda-Domínguez A, de la Cruz-Merino L, Sánchez-Margalet V. 04/03/2025

    Effectiveness and safety of first-line atezolizumab in locally advanced or metastatic urothelial cancer: The IMFLAME study.

    Lista, AGD, Romero-Laorden, N, Gajate, P, Orta-Ruiz, A, Jiménez, JGD, Miranda, MJ, Estévez, SV, Molins, C, Pernaut, C, Cordero, MG, Fernández, O, Sánchez, JG, Maeso, IG, Blazquez, PR, Reig, O, Maroto-Rey, P, Martín, A, Ramirez, I, Puente, J. 10/02/2025

    Ketone Bodies Are Potential Prognostic Biomarkers in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results from the R2-GDP-GOTEL Trial

    Fernández-Castillejo, S, Badia, J, de la Cruz-merino, L, Garcia-Sáncho, AM, Carnicero-González, F, Palazón-Carrión, N, Ríos-Herranz, E, de la Cruz-vicente, F, Rueda-Domínguez, A, Martínez-Banaclocha, N, Gómez-Codina, J, Labrador, J, Martínez-Madueño, F, Amigó, N, Salar-Silvestre, A, Rodríguez-Abreu, D, Gálvez-Carvajal, L, Sánchez-Beato, M, Provencio-Pulla, M, Guirado-Risueño, M, Nogales, E, Sánchez-Margalet, V, Jiménez-Cortegana, C, Rodríguez-García, G, Cumeras, R, Gumà, J, Spanish Lymphoma Oncology Grp GOTEL. 01/02/2025

    Incidence and survival of rare adult solid cancers in Europe (EUROCARE-6): A population-based study

    Trama, A, Bernasconi, A, Cañete, A, Carulla, M, Daubisse-Marliac, L, Rossi, S, De Angelis, R, Sanvisens, A, Katalinic, A, Paapsi, K, Went, P, Mousavi, M, Blum, M, Eberle, A, Lamy, S, Capocaccia, R, Didonè, F, Botta, L. 01/01/2025

    Multi-omics profiling reveals altered mitochondrial metabolism in adipose tissue from patients with metabolic dysfunction-associated steatohepatitis

    Castañé, H, Jiménez-Franco, A, Hernández-Aguilera, A, Martínez-Navidad, C, Cambra-Cortés, V, Onoiu, AI, Jiménez-Aguilar, JM, Paris, M, Hernández, M, Parada, D, Guilarte, C, Zorzano, A, Hernández-Alvarez, MI, Camps, J, Joven, J. 01/01/2025

    PRIMARY PREVENTION OF BREAST CANCER THROUGH THE BRCAPP-ELISAH APP/WEB APPLICATION

    Cesareo, ACA, Verdaguer, MVM, Borgini, ABA, Zachou, MZME, Mazzucco, WMW, Sydor, USU, Saladié, FSF, Sanvisens, ASA, Contiero, PCP. 01/01/2025

    Real-World Data of First-Line Cemiplimab Monotherapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) with PD-L1 Expression = 50%: A National Spanish Multicentric Cohort (CEMI-SPA Study).

    Masini S, Antoñanzas Basa M, Calles A, Cabellos RA, De Elejoste Echebarria I, Traseira Puchol C, Martinez Kareaga M, Cabezon-Gutierrez L, Escoin Perez MC, Lage Y, Garcia Lorenzo E, Navarro F, Sereno M, Falagán Martínez S, García-Benito C, Masfarre Pinto L, Avila Andrade C, Sequero S, Mosquera Martinez J, López-Martín A, Azkárate Martínez A, Martín-Soberón MC, Lucia-Gozalvez C, Rubio J, Tallafigo L, Garrido A, Peressini M, Torres-Jimenez J, Zurera M, Bote H, Ponce S, Paz-Ares L, Zugazagoitia J, Baena J. 13/11/2025

    Epithelial head and neck cancer survival in Europe: Geographical variation, time trends and long term survival.

    Gatta G, Luttmann S, Trama A, Rossi S, Galceran J, Innos K, Guevara M, Licitra L, Bennet D, Redondo-Sánchez D, Capocaccia R. 16/10/2025

    Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial.

    Seguí E, Brasó-Maristany F, Pascual T, Sanfeliu E, Victoria I, Saura C, Hierro C, López-González A, Izarzugaza Y, Ciruelos E, Gavilá J, Racca F, Cejalvo JM, Amillano K, Paz-Ares L, Juan M, Felip E, Garralda E, González B, Arance A, Martín-Liberal J, Conte B, Walbaum B, Indacochea A, Castillo O, Blasco P, Pardo F, Aguirre Á, Sirenko V, González X, Galván P, Vivancos A, Ferrero-Cafiero JM, Mulero-Sánchez A, Salvador F, Villacampa G, Mesía R, Cervantes A, Prat A, Tabernero J. 01/10/2025

    Effectiveness and Safety of Cabozantinib Treatment in Patients with Advanced Renal Cell Carcinoma in Spanish and Portuguese Real-world Practice: The SOGUG-SPRWEC Study.

    Suárez C, Reig Torras Ò, Morales Barrera R, Rodríguez Sánchez Á, Anguera Palacios G, Manshino AMB, Fernández Núñez N, Méndez Vidal MJ, García Carbonero I, Fernández Calvo O, Gironés Sarrió R, Crespo Herrero G, Afonso Afonso J, Juan Fita MJ, Gumà Padró J, Lázaro Quintela M, Rodriguez-Vida A, Hernández Pérez C, Medina Colmenero A, Collado Martín R, Garcías de España C, Molins Palau C, Martínez Ortega E, Gallardo E. 01/10/2025

    Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO study.

    Trujillo-Santos J, García-Escobar I, Salgado M, Araújo A, Martínez-de-Castro E, Molina R, Castellón-Rubio VE, Domènech P, Gallardo E, Colomé E, Torres F, Benítez-Montañez JC, Porta R, Lobo-de-Mena M, Malheiro M, Font C, Brozos-Vázquez E, Garicano F, Sapena V, Costa AL, Albuquerque AC, Cerezuela P. 04/08/2025

    Long-term survival and cure fraction estimates for paediatric central nervous system tumours in 31 European countries (EUROCARE-6): a population-based study.

    Hoogendijk R, Capocaccia R, van der Lugt J, Kranendonk MEG, Hoving EW, Wesseling P, Visser O, van Vuurden DG, Gatta G, Karim-Kos HE. 01/08/2025

    Implementation of a clinical interview guide to Multidimensional needs assessment in Palliative care (MAP): A multicenter mixed-methods feasibility study.

    Crespo I, Goni-Fuste B, Monforte-Royo C, Garcia-Salanova A, Rodríguez-Prat A, Alonso-Babarro A, Alvaro M, Bavestrello P, Belar A, Bottaro D, Candelmi D, Casas E, Costas-Muñoz E, Sequeiros CC, de Iriarte N, De Santiago A, Garrillo J, González-Barboteo J, Ariztia MJ, Vicuña MN, Nitola-Mendoza L, Noguera-Sánchez P, Rocafort J, Rodríguez D, Sala C, Serna J, Torremorell D, Balaguer A, Julià-Torras J. 31/07/2025

    An ambispective, real-world multi-center study of DOstarlimab in patients with Recurrent or Advanced DNA mismatch repair deficient/microsatellite instability-high endometrial cancer (GEICO 120-R/DORA study).

    Gallego A, Madariaga A, Estévez-García P, Albertí F, Carbó A, Palacio I, Churruca C, Gálvez F, Ortega ME, Murata P, Manzano A, Masvidal M, Martín-Lorente C, Hernando B, Lozano I, Cueva JF, García-Illescas D, Gost E, Mendiola M, Redondo A. 01/07/2025

    Prevalence of EGFR gene mutations in patients with early-stage resectable non-small cell lung cancer in Spain: the ORIGEN study.

    Varela M, Teixidó C, Álvarez-Fernández C, Arasanz H, Peralta S, Lázaro M, Calvo V, Álvarez R, Baena J, Valdivia J, Arriola E, Bernabé R, Isla D, Camacho C, Massutí B, Blasco A, García T, Cobo M, Campayo M, Hijazo-Pechero S, Callejo Á, Domínguez M, Nadal E. 30/04/2025

    Elacestrant in Women with Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial.

    Vidal M, Falato C, Pascual T, Sanchez-Bayona R, Muñoz-Mateu M, Cebrecos I, Gonzalez-Farré X, Cortadellas T, Margelí Vila M, Luna MA, Siso C, Amillano K, Galván P, Bergamino MA, Ferrero-Cafiero JM, Salvador F, Espinosa Guerrero A, Pare L, Sanfeliu E, Prat A, Bellet M. 01/04/2025

    Dynamics of molecular heterogeneity in high-risk luminal breast cancer-From intrinsic to adaptive subtyping.

    Denkert C, Rachakonda S, Karn T, Weber K, Martin M, Marmé F, Untch M, Bonnefoi H, Kim SB, Seiler S, Bear HD, Witkiewicz AK, Im SA, DeMichele A, Pehl A, Van’t Veer L, McCarthy N, Stiewe T, Jank P, Gelmon KA, García-Sáenz JA, Westhoff CC, Kelly CM, Reimer T, Felder B, Olivé MM, Knudsen ES, Turner N, Rojo F, Schmitt WD, Fasching PA, Teply-Szymanski J, Zhang Z, Toi M, Rugo HS, Gnant M, Makris A, Holtschmidt J, Nekljudova V, Loibl S. 10/02/2025

    International benchmarking of stage at diagnosis for six childhood solid tumours (the BENCHISTA project): a population-based, retrospective cohort study.

    Botta L, Didonè F, Lopez-Cortes A, Nieto AC, Desandes E, Hjalgrim LL, Jakab Z, Stiller CA, Zeller B, Gatta G, Pritchard-Jones K. 01/02/2025

    Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma

    Benaiges, E, Ceperuelo-Mallafré, V, Guaita, S, Maymó-Masip, E, Madeira, A, Gómez, D, Hernández, V, Vilaseca, I, Merma, C, León, X, Terra, X, Vendrell, J, Avilés-Jurado, FX, Fernández-Veledo, S. 02/02/2024

    Metabolic adaptations in severe obesity: Insights from circulating oxylipins before and after weight loss

    Jiménez-Franco, A, Castañé, H, Martínez-Navidad, C, Placed-Gallego, C, Hernández-Aguilera, A, Fernández-Arroyo, S, Samarra, I, Canela-Capdevila, M, Arenas, M, Zorzano, A, Hernández-Alvarez, MI, Del Castillo, D, Paris, M, Menendez, JA, Camps, J, Joven, J. 01/01/2024

    Socioeconomic inequalities in adherence to clinical practice guidelines and breast cancer survival: a multicentre population-based study in Spain

    Petrova, D, Redondo-Sánchez, D, Rodríguez-Barranco, M, Marcos-Gragera, R, Guevara, M, Carulla, M, de Munain, AL, Vizcaíno, A, del Barco, S, González-Flores, E, Pollán, M, Sánchez, MJ. 31/12/2024

    Ovarian Cancer Retrospective European (O'CaRE) study: first-line outcomes by number of risk factors for progression

    Krell, J, Shaw, D, McGrane, J, Hartkopf, A, Herrero, A, Yeoh, C, Masvidal, M, Raspagliesi, F, York, W, Schilder, JM, Mascialino, B, McDermott, E, Kalilani, L, Hanker, L. 22/12/2024

    SpadaHC: a database to improve and homogenize the classification of variants in hereditary cancer genes in the Spanish population

    Moreno-Cabrera, JM, Feliubadalo, L, Pineda, M, Prada-Dacasa, P, Ramos, M, del Valle, J, Brunet, J, Gel, B, Currás-Freixes, M, Calsina, B, Salazar-Hidalgo, ME, Rodriguez-Balada, M, Bourgine, BR, Fernández, S, Durán, M, Ledo, MA, Sanz, MI, Castillejo, A, Dámaso, E, Soto, JL, de Miguel, M, Calero, BH, Zapardiel, JMS, Cajal, TRY, Lasa, A, Gisbert-Beamud, A, Lopez-Novo, A, Ruiz-Ponte, C, Potrony, M, Alvarez, MI, Osorio, A, Lorda, I, Robledo, M, Cascón, A, Ruiz, A, Spataro, N, Hernan, I, Angosto, EB, Moles-Fernandez, A, Earl, J, Cadiñanos, J, Sánchez-Heras, AB, Bigas, A, Capellá, G, Lázaro, C. 01/12/2024

    SPME arrow-based extraction for enhanced targeted and untargeted urinary volatilomics

    Llambrich, M, Ramírez, N, Cumeras, R, Brezmes, J. 15/11/2024

    Multiplatform metabolomic interlaboratory study of a whole human stool candidate reference material from omnivore and vegan donors

    Cruz, AK, Alves, MA, Andresson, T, Bayless, AL, Bloodsworth, KJ, Bowden, JA, Bullock, K, Burnet, MC, Neto, FC, Choy, A, Clish, CB, Couvillion, SP, Cumeras, R, Dailey, L, Dallmann, G, Davis, WC, Deik, AA, Dickens, AM, Djukovic, D, Dorrestein, PC, Eder, JG, Fiehn, O, Flores, R, Gika, H, Hagiwara, KA, Pham, TH, Harynuk, JJ, Aristizabal-Henao, JJ, Hoyt, DW, Jean-François, F, Kråkström, M, Kumar, A, Kyle, JE, Lamichhane, S, Li, Y, Nam, SL, Mandal, R, de la Mata, AP, Meehan, MJ, Meikopoulos, T, Metz, TO, Mouskeftara, T, Munoz, N, Gowda, GAN, Oresic, M, Panitchpakdi, M, Pierre-Hugues, S, Raftery, D, Rushing, B, Schock, T, Seifried, H, Servetas, S, Shen, T, Sumner, S, Carrillo, KST, Thibaut, D, Trejo, JB, Van Meulebroek, L, Vanhaecke, L, Virgiliou, C, Weldon, KC, Wishart, DS, Zhang, L, Zheng, JM, Da Silva, S. 04/11/2024

    Metabolic profiling of tryptophan pathways: Implications for obesity and metabolic dysfunction-associated steatotic liver disease

    Arto, C, Rusu, EC, Clavero-Mestres, H, Barrientos-Riosalido, A, Bertran, L, Mahmoudian, R, Aguilar, C, Riesco, D, Chicote, JU, Parada, D, Martinez, S, Sabench, F, Richart, C, Auguet, T. 01/11/2024

    P25.03.B RWD OF IDH MUTANT GLIOMAS IN SPAIN, A RETSINE - GEINO STUDY

    Mazariegos, M, Girones, R, Del Barco, S, Garcia, A, Velilla, G, Hernandez, A, Alonso, M, Ferreira, L, Luque, N, Fernández,, Quintanar, T, Peralta, S, Ceballos,, Iza, E, Sanchez, M, Martín, EP, Casado, EA, Mazarico, J, Duran, G, Alvarez, P, Ayala, P, Gallego, O, Sarabia, R, de las Penas, R, Nuñez,, Morilla,, Cunquero, A, Cheverria, N, Moya,, Vaz, M, Luque, R, Esteve, A, Pineda, E. 17/10/2024

    Artificial Intelligence Meets SCLC - Integrating Clinicopathological and Whole-Slide Image Data for Prognostic Prediction in SCLC.

    Rocha, P, Gibert, J, Menendez, S, del Rey-Vergara, R, Iñañez, A, Masfarre, L, Navarro, N, Rios-Hoyo, A, Perez, S, Taus, A, Giner, M, Rovira, A, León-Mateos, L, Isla, D, Paz-Ares, L, Zugazagoitia, J, Blanco, CM, García-Campelo, R, Moreno-Vega, A, Callejo, A, Rojo, F, Sanchez, I, Arriola, E. 01/10/2024

    Estimating cure and risk of death from other causes of cancer patients: EUROCARE-6 data on head & neck, colorectal, and breast cancers

    Botta, L, Capocaccia, R, Bernasconi, A, Rossi, S, Galceran, J, Dal Maso, L, Lepage, C, Molinié, F, Bouvier, AM, Marcos-Gragera, R, Vener, C, Guevara, M, Murray, D, Ragusa, R, Gatta, G, Jooste, V. 01/09/2024

    ABIGAIL: Randomized phase II study of abemaciclib plus endocrine therapy (ET) with or without a short course of induction paclitaxel in patients (pts) with previously untreated HR-positive/HER2-negative advanced breast cancer (HR+/HER2-ABC) with aggressive disease criteria

    Rodriguez, JD, Cortés, J, Di Cosimo, S, López-Barajas, IB, Castedo, SPC, López, A, López-Miranda, E, Juher, HP, Miro, CRA, Ponce, J, Ballerini, VC, Bouzas, LP, Arbizu, MV, Borrego, MRBR, Iranzo, V, Garrido, A, Alcalá-López, D, Mina, L, Mosquera, JJG, Cussac, AL. 01/09/2024

    Real-world data of IDH mutant gliomas in Spain, a RETSINE: GEINO study

    Mazariegos-Rubi, MA, Sarrió, RG, del Barco, S, Castano, AG, Velilla, G, Vinolas, MD, Garcia, MA, Freire, LF, Caro, NL, Perez, IF, Verduguez, TQ, Muñoz, SP, Lenza, IC, Rodriguez, EI, Sanfeliz, C, Martín, EP, Casado, EA, Mazarico, JM, Esteve, A, Pineda, E. 01/09/2024

    Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer

    Di Cosimo, S, Pérez-García, JM, Bellet, M, Dalenc, F, Gil, MJG, Ruiz-Borrego, M, Gavilá, J, Aguirre, E, Schmid, P, Marmé, F, Gligorov, J, Schneeweiss, A, Albanell, J, Zamora, P, Wheatley, D, de Dueñas, EM, Amillano, K, Shimizu, E, Sampayo-Cordero, M, Cortés, J, Llombart-Cussac, A. 01/08/2024

    First-line PARP inhibitor maintenance treatment in ovarian carcinoma for older adult women: a review of the current literature

    Hernandez, MM, Costa, SC, Coloma, CS, Cutillas, AQ, Barretina-Ginesta, MP, Sanchís, AC. 19/07/2024

    Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer

    Peressini, M, Garcia-Campelo, R, Massuti, B, Marti, C, Cobo, M, Gutiérrez, V, Dómine, M, Fuentes, J, Majem, M, de Castro, J, Córdoba, JF, Diz, MP, Isla, D, Esteban, E, Carcereny, E, Vila, L, Moreno-Vega, A, Ros, S, Moreno, A, García, FJ, Huidobro, G, Aguado, C, Cebey-López, V, Valdivia, J, Palmero, R, Lianes, P, López-Brea, M, Vidal, OJ, Provencio, M, Arriola, E, Baena, J, Herrera, M, Bote, H, Molero, M, Adradas, V, Ponce-Aix, S, Nuñez-Buiza, A, Ucero, A, Hernandez, S, Lopez-Rios, F, Conde, E, Paz-Ares, L, Zugazagoitia, J. 15/07/2024

    SpadaHC: a database to improve the classification of variants in hereditary cancer genes in the Spanish population

    Moreno-Cabrera, JM, Feliubadaló, L, Pineda, M, Prada-Dacasa, P, Ramos-Muntada, M, Del Valle, J, Brunet, J, Gel, B, Currás-Freixes, M, Calsina, B, Salazar-Hidalgo, ME, Rodríguez-Balada, M, Roig, B, Fernández-Castillejo, S, Domínguez, MD, Ledo, MA, Sanz, MI, Castillejo, A, Dámaso, E, Soto, JL, de Miguel, M, Calero, BH, Sánchez-Zapardiel, JM, Ramon, T, Lasa, A, Gisbert-Beamud, A, López-Novo, A, Ruiz-Ponte, C, Potrony, M, Alvarez-Mora, M, Osorio, A, Lorda-Sánchez, I, Robledo, M, Cascon, A, Ruiz, A, Spataro, N, Hernan, I, Borràs, E, Moles-Fernández, A, Earl, J, Cadiñanos, J, Sánchez-Heras, AB, Bigas, A, Capellá, G, Lazaro, C. 04/07/2024

    A red-fleshed apple rich in anthocyanins improves endothelial function, reduces inflammation, and modulates the immune system in hypercholesterolemic subjects: the AppleCOR study

    Pedret, A, Companys, J, Calderón-Pérez, L, Llauradó, E, Pla-Pagà, L, Salamanca, P, Sandoval-Ramírez, BA, Catalán, U, Fernández-Castillejo, S, Yuste, S, Macià, A, Gutiérrez-Tordera, L, Bulló, M, Camps, J, Canela, N, Valls, RM, Rubió-Piqué, L, Motilva, MJ, Solà, R. 04/06/2024

    Primary results from PATRICIA cohort C (SOLTI-1303), a randomized phase II study evaluating palbociclib with trastuzumab and endocrine therapy in pretreated HER2-positive and PAM50 luminal advanced breast cancer

    Ciruelos, E, Pascual, T, Villacampa, G, Pernas, S, Sanchez-Bayona, R, Ponce-Lorenzo, JJ, de Ibarguren, BCS, Escrivá-de-Romaní, S, Perello, A, Montaño, A, Martinez, E, González, AL, Olivé, MM, De La Haba, J, Cortes, J, Oliveira, M, Villanueva, L, Gonzalez, X, Villagrasa, P, Prat, A. 01/06/2024

    Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)

    Gately, L, Mesía, C, Sepúlveda, JM, del Barco, S, Pineda, E, Gironés, R, Fuster, J, Dumas, M, Gill, S, Navarro, LM, Herrero, A, Dowling, A, de las Peñas, R, Vaz, MA, Alonso, M, Lwin, Z, Harrup, R, Peralta, S, Long, A, Perez-Segura, P, Ahern, E, Garate, CO, Wong, M, Campbell, R, Cuff, K, Jennens, R, Gallego, O, Underhill, C, Martinez-Garcia, M, Covela, M, Cooper, A, Brown, S, Rosenthal, M, Torres, J, Collins, IM, Gibbs, P, Balana, C. 01/06/2024

    Validation of prognostic and predictive value of total tumoral load after primary systemic therapy in breast cancer using OSNA assay

    Bernet-Vegué, L, Cantero-González, C, de Salas, MS, Parada, D, Perin, T, Quintero-Niño, Z, Pérez-Quintela, BV, Sánchez-Guzman, D, Castelvetere, M, Hernaez, DH, Martín-Salvago, MD. 01/05/2024

    Changes in oxidative stress and the inflammatory system in breast cancer patients

    Avila, VDC, Franco, AJ, Capdevila, MC, Pablo, RG, Aguilar, JMJ, Casta , H, Mora, PA, Chac n, BAM, Benitez, G, Acosta, JC, Benavides, R, Troncho, CE, Engel, O, Parada, D, De la Flor, M, Jord , C, Mel , M, Repkova, J, Prat, MA. 01/05/2024

    Metabolic profiling of plasma and tissue in breast cancer patients: uncovering therapeutic response

    Jim nez-Franco, A, Calder n, D, Jim nez-Aguilar, J, Canela-Capdevila, M, Garc a-Pablo, R, Casta , H, Araguas, P, Malave, B, Acosta, JC, Benavides, R, Arquez, M, Casta o, F, Riu, F, De la Flor, M, Jord , C, Mel , M, Repkova, J, Amillano, K, Camps, J, Joven, J, Arenas, M. 01/05/2024

    Optimal [18F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain Trial

    Gebhart, G, Keyaerts, M, Guiot, T, Flamen, P, Ruiz-Borrego, M, Stradella, A, Bermejo, B, Escriva-de-Romani, S, Martínez, LC, Ribelles, N, Fernandez-Abad, M, Albacar, C, Colleoni, M, Garrigos, L, de Frutos, MA, Dalenc, F, Prat, A, Marmé, F, Schmid, P, Kerrou, K, Braga, S, Gener, P, Sampayo-Cordero, M, Cortés, J, Pérez-García, JM, Llombart-Cussac, A. 01/05/2024

    3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial

    Pérez-García, JM, Cortés, J, Ruiz-Borrego, M, Colleoni, M, Stradella, A, Bermejo, B, Dalenc, F, Escrivá-de-Romaní, S, Martínez, LC, Ribelles, N, Marmé, F, Cortés, A, Albacar, C, Gebhart, G, Prat, A, Kerrou, K, Schmid, P, Braga, S, Di Cosimo, S, Gion, M, Antonarelli, G, Popa, C, Szostak, E, Alcalá-López, D, Gener, P, Rodríguez-Morató, J, Mina, L, Sampayo-Cordero, M, Llombart-Cussac, A. 27/04/2024

    Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer

    Torres-Esquius, S, Llop-Guevara, A, Gutiérrez-Enríquez, S, Romey, M, Teulé, A, Llort, G, Herrero, A, Sánchez-Henarejos, P, Vallmajó, A, González-Santiago, S, Chirivella, I, Cano, JM, Graña, B, Simonetti, S, de Corcuera, ID, Cajal, TRY, Sanz, J, Serrano, S, Otero, A, Churruca, C, Sánchez-Heras, AB, Servitja, S, Guillén-Ponce, C, Brunet, J, Denkert, C, Serra, V, Balmaña, J. 22/04/2024

    Easy-Amanida: An R Shiny application for the meta-analysis of aggregate results in clinical metabolomics using Amanida and Webchem

    Llambrich, M, Satorra, P, Correig, E, Gumà, J, Brezmes, J, Tebé, C, Cumeras, R. 13/03/2024

    A Descriptive Study of 103 Primary Cutaneous B-Cell Lymphomas: Clinical and Pathological Characteristics and Treatment from the Spanish Lymphoma Oncology Group (GOTEL)

    Martínez-Banaclocha, N, Martínez-Madueño, F, Caballé, B, Badia, J, Blanes, M, Bujanda, DA, Calvo, V, Codina, JG, Blanco, CQ, Espinosa, P, Lavernia, J, Arroyo, FRG, Risueño, MG, Llorca, C, Cumeras, R, Pulla, MP, Gumà, J. 01/03/2024

    Influence of chemotherapy regimens prior to nivolumab on the survival of recurrent/metastatic SCCHN.

    Blanco, CM, Palomares, LD, Gonzálvez, CL, Muñoz, SP, Laguna, VM, Llansa, LA, Gómez, DG, Mejía, MM, Pinel, MA, Linares, CM, Padró, JG. 01/03/2024

    Adherence to clinical practice guidelines: a population-based study of socio-economic inequalities in breast cancer

    Petrova, D, Sánchez, DR, Rodríguez-Barranco, M, Carulla, M, Guevara, M, de Munain, AL, Vizcaíno, A, Marcos-Gragera, R, González-Flores, E, Sant, M, Pollán, M, Sánchez-Pérez, MJ. 01/03/2024

    CD8+NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma

    Hontecillas-Prieto, L, García-Domínguez, DJ, Palazón-Carrión, N, García-Sancho, AM, Nogales-Fernández, E, Jiménez-Cortegana, C, Sánchez-León, ML, Silva-Romeiro, S, Flores-Campos, R, Carnicero-González, F, Ríos-Herranz, E, de la Cruz-vicente, F, Rodríguez-García, G, Fernández-Alvarez, R, Martínez-Banaclocha, N, Gumà-Padrò, J, Gómez-Codina, J, Salar-Silvestre, A, Rodríguez-Abreu, D, Gálvez-Carvajal, L, Labrador, J, Guirado-Risueño, M, Provencio-Pulla, M, Sánchez-Beato, M, Marylene, L, Alvaro-Naranjo, T, Casanova-Espinosa, M, Rueda-Domínguez, A, Sánchez-Margalet, V, de la Cruz-merino, L. 26/02/2024

    Atypical Presentation of an Ovarian Yolk Sac Tumor in an 80-Year-Old Woman: A Case Report and Review of the Literature

    Maldonado, V, Masvidal, M, Laguna, VM, Cimerman, J, Soriano, SM. 01/01/2024

    Current Practices in LC-MS Untargeted Metabolomics: A Scoping Review on the Use of Pooled Quality Control Samples.

    Broeckling CD, Beger RD, Cheng LL, Cumeras R, Cuthbertson DJ, Dasari S, Davis WC, Dunn WB, Evans AM, Fernández-Ochoa A, Gika H, Goodacre R, Goodman KD, Gouveia GJ, Hsu PC, Kirwan JA, Kodra D, Kuligowski J, Lan RS, Monge ME, Moussa LW, Nair SG, Reisdorph N, Sherrod SD, Ulmer Holland C, Vuckovic D, Yu LR, Zhang B, Theodoridis G, Mosley JD. 26/12/2023

    Childhood and Adolescent Central Nervous System Tumours in Spain: Incidence and Survival over 20 Years: A Historical Baseline for Current Assessment.

    Chirlaque MD, Peris-Bonet R, Sánchez A, Cruz O, Marcos-Gragera R, Gutiérrez-Ávila G, Quirós-García JR, Almela-Vich F, López de Munain A, Sánchez MJ, Franch-Sureda P, Ardanaz E, Galceran J, Martos C, Salmerón D, Gatta G, Botta L, Cañete A, The Spanish Childhood Cancer Epidemiology Working Group. 18/12/2023

    A Metabolites Merging Strategy (MMS): Harmonization to Enable Studies' Intercomparison.

    Villalba H, Llambrich M, Gumà J, Brezmes J, Cumeras R. 21/11/2023

    SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022)

    Gumà, J, Palazón-Carrión, N, Rueda-Domínguez, A, Sequero, S, Calvo, V, García-Arroyo, R, Gómez-Codina, J, Llanos, M, Martínez-Banaclocha, N, Provencio, M. 01/09/2023

    Opportunistic genetic screening increases the diagnostic yield and is medically valuable for care of patients and their relatives with hereditary cancer

    Fernández-Castillejo, S, Roig, B, Melé, M, Serrano, S, Salvat, M, Querol, M, Brunet, J, Pineda, M, Cisneros, A, Parada, D, Badia, J, Borràs, J, Rodríguez-Balada, M, Gumà, J. 17/08/2023

    Blood Liquid Biopsy in an Advanced Medullary Thyroid Carcinoma: A Case Study with Rearranged during Transfection Heterogeneity

    Gumà, J, Peña, KB, Riu, F, Lucia-Gozálvez, C, Vidaller, A, Maldonado, V, Parada, D. 01/08/2023

    Differences in the Stool Metabolome between Vegans and Omnivores: Analyzing the NIST Stool Reference Material

    Cumeras, R, Shen, T, Valdiviez, L, Tippins, Z, Haffner, B, Fiehn, O. 01/08/2023

    Incidence and time trends of childhood hematological neoplasms: a 36-year population-based study in the southern European context, 1983-2018

    Trallero, J, Sanvisens, A, Vich, FA, El Karoni, NJ, Lloret, IS, Díaz-del-Campo, C, Marcos-Navarro, AI, Atxega, AA, Uriarte, PS, Ortega, MD, Sánchez, MJ, Perucha, J, Franch, P, Chirlaque, MD, Guevara, M, Ameijide, A, Galceran, J, Ramírez, C, Camblor, MR, Alemán, MA, Gutiérrez, P, Marcos-Gragera, R. 25/07/2023

    Study of Liquid-Based Cytology Using Next-Generation Sequencing as a Liquid Biopsy Application in Patients with Advanced Oncological Disease

    Peña, KB, Riu, F, Hernandez, A, Guilarte, C, Elizalde-Horcada, M, Parada, D. 01/06/2023

    Exploring the circulatory metabolic alterations in breast cancer patients

    Franco, AJ, Tomàs, ER, Lluis, CP, Vilafranca, HC, Gaya, GB, Araguas, P, Malave, B, Calderón, D, Acosta, JC, Arquez, M, Benavides, R, Riu, F, De la Flor, M, Jordà, C, Melé, M, Repkova, J, Sabater, S, Camps, J, Joven, J, Arenas, M. 01/05/2023

    SUCNR1 signaling in adipocytes controls energy metabolism by modulating circadian clock and leptin expression

    Villanueva-Carmona, T, Cedó, L, Madeira, A, Ceperuelo-Mallafré, V, Rodríguez-Peña, MM, Núñez-Roa, C, Maymó-Masip, E, Repollés-de-Dalmau, M, Badia, J, Keiran, N, Mirasierra, M, Pimenta-Lopes, C, Sabadell-Basallote, J, Bosch, R, Caubet, L, Escolà-Gil, JC, Fernández-Real, JM, Vilarrasa, N, Ventura, F, Vallejo, M, Vendrell, J, Fernández-Veledo, S. 04/04/2023

    Retrospective Analysis of Vaccination Status and Predominant Viral Variants in Patients Hospitalized with COVID-19 in Reus, Spain

    Iftimie, S, López-Azcona, AF, Lozano-Olmo, MJ, Naval-Ferrando, A, Domingo-Cortés, V, Castañé, H, Jiménez-Franco, A, Hernández-Aguilera, A, Guilarte, C, Riu, F, Camps, J, Joven, J, Castro, A. 01/04/2023

    SARS-CoV-2 Serum Viral Load and Prognostic Markers Proposal for COVID-19 Pneumonia in Low-Dose Radiation Therapy Treated Patients

    Piqué, B, Peña, K, Riu, F, Acosta, JC, Torres-Royo, L, Malave, B, Araguas, P, Benavides, R, De Febrer, G, Camps, J, Joven, J, Arenas, M, Parada, D. 01/02/2023

    Increased Hepatic ATG7 mRNA and ATG7 Protein Expression in Nonalcoholic Steatohepatitis Associated with Obesity

    Barrientos-Riosalido, A, Real, M, Bertran, L, Aguilar, C, Martinez, S, Parada, D, Vives, M, Sabench, F, Riesco, D, Castillo, DD, Richart, C, Auguet, T. 10/01/2023

    Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study

    Fernández-Miranda, I, Pedrosa, L, Llanos, M, Franco, FF, Gómez, S, Martín-Acosta, P, García-Arroyo, FR, Gumá, J, Horcajo, B, Ballesteros, AK, Gálvez, L, Martínez, N, Marín, M, Sequero, S, Navarro, M, Yanguas-Casás, N, Calvo, V, Rueda-Domínguez, A, Provencio, M, Sánchez-Beato, M. 01/01/2023

    GCIMS: An R package for untargeted gas chromatography - Ion mobility spectrometry data processing

    Oller-Moreno, S, Mallafré-Muro, C, Fernandez, L, Caballero, E, Blanco, A, Gumà, J, Marco, S, Pardo, A. 15/10/2023

    Gene expression profiling in tumors with and without tertiary lymphoid structures across cancer-types

    Solis, ES, Pascual, T, Torres, ES, Gonzalez-Farre, B, Brasó-Maristany, F, Farre, XG, Salvador, F, Felip, E, Garralda, E, Paz-Ares, L, Otero, MJ, Nin, RM, Fernandez, AMA, Cervantes, A, Martin-Liberal, J, Gavilá-Gregori, J, Parraga, KA, Racca, FE, Tabernero, J, Prat, A. 01/10/2023

    Treatment of COVID-19 pneumonia with low-dose radiotherapy plus standard of care versus standard of care alone in frail patients The SEOR-GICOR IPACOVID comparative cohort trial

    Arenas, M, Piqué, B, Torres-Royo, L, Acosta, JC, Rodríguez-Tomàs, E, De Febrer, G, Vasco, C, Araguas, P, Gómez, JA, Malave, B, Arquez, M, Algara, M, Montero, A, Montero, M, Simó, JM, Gabaldó, X, Parada, D, Riu, F, Sabater, S, Camps, J, Joven, J. 01/09/2023

    Treatment with anticancer drugs for advanced pancreatic cancer: a systematic review

    Salazar, J, Bracchiglione, J, Savall-Esteve, O, Antequera, A, Bottaro-Parra, D, Gutiérrez-Valencia, M, Martínez-Peralta, S, Pericay, C, Tibau, A, Bonfill, X. 12/08/2023

    Matrix Metalloproteinase-9 Expression Is Associated with the Absence of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients

    Lejeune, M, Reverté, L, Gallardo, N, Sauras, E, Bosch, R, Mata, D, Roso, A, Petit, A, Peg, V, Riu, F, Garcia-Fontgivell, J, Relea, F, Vieites, B, de la Cruz-merino, L, Arenas, M, Rodriguez, V, Galera, J, Korzynska, A, Plancoulaine, B, Alvaro, T, López, C. 01/07/2023

    Olaparib (O) in advanced triple negative breast cancer (aTNBC) patients (pts) with BRCA1/2 promoter methylation: GEICAM/2015-06 study (COMETA-Breast)

    De La Haba, J, Anton, A, Quiroga, V, Guerrero, A, Andres, R, Mele, M, Gonzalez-Santiago, S, Perez-Fidalgo, JA, Cajal, TRY, Escudero, MJ, Bezares, S, Caballero, R, Rojo, F. 01/06/2023

    Detection of circulating tumor DNA following neoadjuvant chemotherapy and surgery to anticipate early relapse in ER positive and HER2 negative breast cancer: Analysis from the PENELOPE-B trial.

    Turner, NC, Marmé, F, Kim, SB, Bonnefoi, HR, García-Sáenz, J, Torres, AA, Bear, HD, Tesch, H, Olivé, MM, Mc Carthy, N, Jurado, JC, Im, SA, Liu, Y, Zhang, Z, Weber, KE, Felder, B, Nekljudova, V, Reimer, T, Denkert, C, Loibl, S. 01/06/2023

    Treatment of COVID-19 pneumonia with low-dose radiotherapy in frail patients

    Chacon, BAM, Arteaga, JCA, Piqué, B, Torres-Royo, L, Rodríguez-Tomás, E, Benavides, R, De Febrer, G, Araguas, P, Gomez, JA, Arquez, M, Calderon, VD, Algara, M, Montero, A, Parada, D, Riu, F, Jiménez, A, Vasco, C, Sabater, S, Camps, J, Joven, J, Prat, MA. 01/05/2023

    Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response

    Lejeune, M, Reverté, L, Sauras, E, Gallardo, N, Bosch, R, Roso, A, Petit, A, Peg, V, Riu, F, García-Fontgivell, J, Ibáñez, J, Relea, F, Vieites, B, Bor, C, de la Cruz-Merino, L, Arenas, M, Rodriguez, V, Galera, J, Korzynska, A, Belhomme, P, Plancoulaine, B, Alvaro, T, López, C. 01/02/2023

    Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial

    Tibau, A, Martinez, MT, Ramos, M, de la Cruz-merino, L, Santaballa, A, O’Connor, M, Martinez-Janez, N, Moreno, F, Fernandez, I, Virizuela, JA, Alarcon, J, de la Haba-rodriguez, J, Sanchez-Rovira, P, Albacar, CR, Muino, CB, Kelly, C, Casas, M, Bezares, S, Rosell, L, Albanell, J. 01/01/2023

    Ten-Year Probabilities of Death Due to Cancer and Cardiovascular Disease among Breast Cancer Patients Diagnosed in North-Eastern Spain.

    Clèries R, Ameijide A, Buxó M, Vilardell M, Martínez JM, Font R, Marcos-Gragera R, Puigdemont M, Viñas G, Carulla M, Espinàs JA, Galceran J, Izquierdo Á, Borràs JM. 27/12/2022

    Immunohistochemical Algorithm for the Classification of Muscle-Invasive Urinary Bladder Carcinoma with Lymph Node Metastasis: An Institutional Study

    Peña, KB, Riu, F, Gumà, J, Martínez-Madueño, F, Miranda, MJ, Vidal, A, Grifoll, M, Badia, J, Rodriguez-Balada, M, Parada, D. 01/12/2022

    Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study

    Villarroel, PG, Padro, JG, Marquina, G, Janez, NM, Gonzalez, EE, Anton, A, Sanchez, MB, Caceres, AR, Lopez-Lopez, R, Cornejo, RE, Garcia, PB, Fabregat, RM, Fernandez, BC, Bermudo, CL, Camps, C. 01/12/2022

    Utility of ctDNA Liquid Biopsies from Cancer Patients: An Institutional Study of 285 ctDNA Samples

    Gumà, J, Peña, K, Riu, F, Guilarte, C, Hernandez, A, Lucía, C, Martínez-Madueño, F, Miranda, MJ, Cabezas, I, Grifoll, M, Peralta, S, Serrano, S, Muñoz, F, Delamo, L, Roig, B, Borràs, J, Badia, J, Rodriguez-Balada, M, Parada, D. 01/12/2022

    The untargeted urine volatilome for biomedical applications: methodology and volatilome database

    Llambrich, M, Brezmes, J, Cumeras, R. 01/12/2022

    Incidence and survival of lymphoid neoplasms in Spain, 2002-2013: A population-based study from the Spanish Network of Cancer Registries (REDECAN)

    Pla, C, Solans, M, Ameijide, A, Sanvisens, A, Carulla, M, Rojas, MD, Alemán, MA, Sáez-Lloret, I, Díaz-Del-Campo, C, Marcos-Navarro, AI, Sainz-de-Aja, L, Aizpurua-Atxega, A, Lopez-de-Munain, A, Sánchez, MJ, Perucha, J, Franch, P, Chirlaque, MD, Guevara, M, Galceran, J, Merino, S, Marcos-Gragera, R. 24/11/2022

    The 2022 ENCR Recommendations on recording and reporting of urothelial tumours of the urinary tract

    Galceran, J, Parada, D, Eden, M, Tumino, R, Warren, AY, Martos, C, Neamtiu, L, Visser, O, Daubisse-Marliac, L. 23/11/2022

    SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA

    Prat, A, Paz-Ares, L, Juan, M, Felip, E, Garralda, E, Gonzalez, B, Arance, A, Martin-Liberal, J, Gavila, J, Lopez-Gonzalez, A, Cejalvo, JM, Izarzugaza, Y, Amillano, K, Corbacho, JG, Saura, C, Racca, F, Hierro, C, Sanfeliu, E, Gonzalez, X, Canes, J, Villacampa, G, Salvador, F, Pascual, T, Mesia, R, Cervantes, A, Tabernero, J. 01/11/2022

    Long-term breast cancer risk after benign breast disease in population-based screening

    Roman, M, Louro, J, Vázquez, I, Saladieprime, F, Penalva, L, Bargalló, X, Quintana, MJ, Del Riego, J, Vidal, C, Castells, X. 01/11/2022

    Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01)

    Aparicio, J, Manrique, ACV, Capdevila, J, Boza, FM, Galván, P, Richart, P, Oliveres, H, Páez, D, Hernando, J, Serrano, S, Vera, R, Hernandez-Yagüe, X, Gallego, RA, Riesco-Martinez, MC, de Albeniz, XG, Maurel, J. 01/11/2022

    Urine NMR Metabolomics for Precision Oncology in Colorectal Cancer

    Brezmes, J, Llambrich, M, Cumeras, R, Gumà, J. 01/10/2022

    Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: A population-based in 9 countries

    Cardoso, R, Guo, F, Heisser, T, De Schutter, H, Van Damme, N, Nilbert, MC, Christensen, J, Bouvier, AM, Bouvier, V, Launoy, G, Woronoff, AS, Cariou, M, Robaszkiewicz, M, Delafosse, P, Poncet, F, Walsh, PM, Senore, C, Rosso, S, Lemmens, VEPP, Elferink, MAG, Tomsic, S, Zagar, T, Marques, ALD, Marcos-Gragera, R, Puigdemont, M, Galceran, J, Carulla, M, Sánchez-Gil, A, Chirlaque, MD, Hoffmeister, M, Brenner, H. 01/10/2022

    Phase IIIb study of durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Preliminary efficacy results

    Isla, D, Arriola, E, Campelo, MRG, Tain, PD, Blanco, CM, Piqueras, MMLB, Vega, ALM, Mateos, LAL, Rodriguez, JMO, Calderon, VG, Tarruella, MM, Hernandez, AS, de la Rosa, CA, Cabellos, RA, Ciriquian, JLM, Paul, AM, Perez, JLF, Mellen, AC, Baez, L, Paz-Ares, L. 01/09/2022

    Multicenter Real-World Data of Subsequent Chemotherapy after Progression to PARP Inhibitors in a Maintenance Relapse Setting

    Romeo, M, Gil-Martin, M, Gaba, L, Teruel, I, Taus, A, Fina, C, Masvidal, M, Murata, P, Fernandez-Plana, J, Martinez, A, Perez, C, Garcia, Y, Rodriguez, V, Cros, S, Parera, M, Zanui, M, Catot, S, Pardo, B, Plaja, A, Esteve, A, Barretina-Ginesta, MP. 01/09/2022

    Prognostic value of PD-L1 in patients with metastatic renal cell carcinoma (mRCC) treated with antiangiogenic first line drugs (PROANG-SOGUG study)

    Gómez, CI, Lorenzo, VB, Dominguez, RG, Carbonero, IG, Feliciangeli, E, Ruiz, SG, de Liaño, AG, Valderrama, BP, Sanchez, AR, Sánchez-Escribano, R, Rodriguez, CS, Quintela, ML, Diaz, EG, Padro, JGI, Puente, J, Guzman, JCV, Sanchez, JG, Kareaga, MM, Zambrano, MDCB, Molina-Cerrillo, J. 01/09/2022

    Patients with initial nodal involvement due to breast cancer who have received neoadjuvant chemotherapy: Combined sentinel node-radioguided surgery of the pathological node

    Manuel, JF, Kohan, S, Solé, MJ, Hidalgo, IM, Curto, MM, Sagristà, OA, Alomá, EA, González, KP, Torres, AL, Olivé, MM, Repkova, J, Jaime, MJM, Padró, JG. 01/09/2022

    Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis

    Palazón-Carrión, N, García-Sancho, AM, Nogales-Fernández, E, Jiménez-Cortegana, C, Carnicero-González, F, Ríos-Herranz, E, de la Cruz-Vicente, F, Rodríguez-García, G, Fernández-Alvarez, R, Martínez-Banaclocha, N, Gumà-Padrò, J, Gómez-Codina, J, Salar-Silvestre, A, Rodríguez-Abreu, D, Gálvez-Carvajal, L, Labrador, J, Guirado-Risueño, M, García-Domínguez, DJ, Hontecillas-Prieto, L, Espejo-García, P, Fernández-Román, I, Provencio-Pulla, M, Sánchez-Beato, M, Navarro, M, Marylene, L, Alvaro-Naranjo, T, Casanova-Espinosa, M, Sánchez-Margalet, V, Rueda-Domínguez, A, de la Cruz-Merino, L. 01/09/2022

    Breast cancer detection by analyzing the volatile organic compound (VOC) signature in human urine

    Benet, JG, Seo, M, Khine, M, Padró, JG, Martnez, AP, Kurdahi, F. 01/09/2022

    Patients with initial nodal involvement due to breast cancer who have received neoadjuvant chemotherapy: Combined sentinel node-radioguided surgery of the pathological node.

    Fuertes Manuel J, Kohan S, Jordà Solé M, Mateu Hidalgo I, Miralles Curto M, Aguiló Sagristà O, Aguilar Alomá E, Peña González K, Lafuerza Torres A, Melé Olivé M, Repkova J, Montero Jaime MJ, Gumà Padró J. 01/09/2022

    Proportion and stage distribution of screen-detected and non-screen-detected colorectal cancer in nine European countries: an international, population-based study

    Cardoso, R, Guo, F, Heisser, T, De Schutter, H, Van Damme, N, Nilbert, MC, Tybjerg, AJ, Bouvier, AM, Bouvier, V, Launoy, G, Woronoff, AS, Cariou, M, Robaszkiewicz, M, Delafosse, P, Poncet, F, Walsh, PM, Senore, C, Rosso, S, Lemmens, VEPP, Elferink, MAG, Tomsic, S, Zagar, T, Marques, ALD, Marcos-Gragera, R, Puigdemont, M, Galceran, J, Carulla, M, Sánchez-Gil, A, Chirlaque, MD, Hoffmeister, M, Brenner, H. 01/08/2022

    The role of specialist nurses in detecting spasticity and related symptoms in multiple sclerosis

    Artola, M, Hernando, A, Vidal, O, Vidal, N, Cuenca, E, Horno, R, Robles, MA, Oriol, C, Peralta, S, Solana, MAJ, Rubio, M, Montero, C, Lleixa, M, Zabay, C, Martin, M, Leon, I, Molinos, C, Matamoros, M, Mercade, L, Fornali, O, Montero, L, Saiz, A, Sola-Valls, N. 07/07/2022

    Role of survivin on radioresistance and metabolism in the context of head and neck squamous cell carcinoma

    Benaiges, E, Ceperuelo-Mallafré, V, Guaita, S, Madeira, A, Vendrell, J, Avilés, FX, Fernández-Veledo, S. 01/07/2022

    Usefulness of the Urine Methylation Test (Bladder EpiCheck®) in Follow-Up Patients with Non-Muscle Invasive Bladder Cancer and Cytological Diagnosis of Atypical Urothelial Cells-An Institutional Study

    Peña, KB, Riu, F, Hernandez, A, Guilarte, C, Badia, J, Parada, D. 01/07/2022

    Immunocytochemical Assessment of ACE2 and TMPRSS2 in Nasopharyngeal Swabs from SARS-CoV-2 Patients

    Peña, KB, Gumà, J, Guilarte, C, Delamo, L, Grifol, M, Pique, B, Hernandez, A, Casteñé, H, Riu, F, Parada, D. 24/06/2022

    Identification of Mobility Patterns of Clusters of City Visitors: An Application of Artificial Intelligence Techniques to Social Media Data

    Orama, JA, Huertas, A, Borràs, J, Moreno, A, Clavé, SA. 01/06/2022

    SOLTI-1303 PATRICIA: Cohort C. Combination of palbociclib with trastuzumab and endocrine therapy (ET) versus treatment of physician's choice (TPC) in pretreated HER2-positive and hormone receptor-positive (HER2+/HR+)/PAM50 luminal metastatic breast cancer (BC): A randomized phase II trial

    Ciruelos, EM, Ponce, J, Simon, SP, Cortes, J, Cantos, B, Garate, E, Alonso, EV, Olive, MM, De Duenas, EM, Perianez, AM, Martinez, N, Martorell, AP, De las Heras, BB, Nunez, CA, Fernandez, I, Rodriguez, JD, Oliveira, M, Gonzalez, X, Gonzalez, PV, Prat, A. 01/05/2022

    Optimal 18F-FDG PET/CT (FDG-PET) cut-off for pathological complete response (pCR) prediction in HER2-positive [HER2+] early breast cancer (EBC) patients (pts) treated with neoadjuvant trastuzumab (T) and pertuzumab (P) in PHERGain trial

    Gebhart, G, Keyaerts, M, Guiot, T, Flamen, P, Borrego, MR, Stradella, A, De Las Heras, BB, de Romani, SE, Calvo-Martinez, L, Entrena, NR, Martinez, N, Miro, CRA, Colleoni, MA, de Frutos, MA, Sampayo-Cordero, M, Cortes, J, Garcia, JMP, Cussac, AL. 01/05/2022

    Preliminary evaluation of venous thromboembolic risk in patients with colorectal cancer from the CARTAGO study

    Salgado, M, Molina, R, Vazquez, EB, Martinez, E, Cillan, E, Fullana, T, Villa, JC, Lobo, M, Masvidal, M, Porta, R, Campos, B, Garicano, F, Pampols, M, Fernandez, I, Font, C, Martinez, P, Gutierrez, D, Horvath, E, Costa, AL, Malheiro, M, Arias, D. 01/05/2022

    Cancer Survival in Adults in Spain: A Population-Based Study of the Spanish Network of Cancer Registries (REDECAN)

    Guevara, M, Molinuevo, A, Salmerón, D, Marcos-Gragera, R, Carulla, M, Chirlaque, MD, Camblor, MR, Alemán, A, Rojas, D, Batllés, AV, Chico, M, Chillarón, RJ, de Munain, AL, de Castro, V, Sánchez, MJ, Ramalle-Gómara, E, Franch, P, Galceran, J, Ardanaz, E. 01/05/2022

    Clinical Outcome and Radiologic Changes in SARS-CoV-2 Pneumonia treated with Low-Dose Radiotherapy.

    Arteaga, JCA, Royo, LT, Rodríguez-Tomás, E, De Febrer, G, Vasco, C, Gomez, JA, Araguas, P, Malave, B, Arquez, M, Algara, M, Montero, A, Montero, M, Simo, JM, Gavaldà, X, Pique, B, Parada, D, Sabater, S, Camps, J, Joven, J, Arenas, M. 01/05/2022

    Descriptive study of mutation status and clinical phenotype in breast cancer patients of South Catalonia

    Cochs, A, Balada, MR, Bourgine, BR, Castillejo, SF, Miro, CRA, Palomares, LD, Garcia, MQ, Casas, MS, Repkova, J, Hernandez, MM, Solares, SS, Parraga, KA, Olive, MM, Gumà, J. 01/05/2022

    Phase IIIb study of durvalumab plus platinumeetoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Treatment patterns of chemotherapy combination phase with durvalumab

    Isla, D, Arriola, E, Campelo, MRG, Marti, C, Tain, PD, Vega, ALM, Piqueras, MLB, Leon, L, Calderon, VG, Rodriguez, JMO, Majem, M, Sanchez-Hernandez, A, de la Rosa, CA, Cabellos, RA, Marti-Ciriquian, JL, Paul, AM, Cordero, MG, Mellen, AC, Baez, L, Zugazagoitia, J. 01/04/2022

    Registration of Urothelial Tumours in Cancer Registries: How to Improve and Make It More Useful?

    Daubisse-Marliac, L, Grosclaude, P, Carulla, M, Parada, D, Vilardell, L, Ameijide, A, Marcos-Gragera, R, Galceran, J. 01/03/2022

    Long-Term Risk of Breast Cancer after Diagnosis of Benign Breast Disease by Screening Mammography

    Roman, M, Louro, J, Posso, M, Vidal, C, Bargallo, X, Vazquez, I, Quintana, MJ, Alcantara, R, Saladie, F, del Riego, J, Penalva, L, Sala, M, Castells, X. 01/03/2022

    A European, prospective, observational study of enzalutamide in patients with metastatic castration-resistant prostate cancer: PREMISE

    Payne, H, Robinson, A, Rappe, B, Hilman, S, De Giorgi, U, Joniau, S, Bordonaro, R, Mallick, S, Dourthe, LM, Flores, MM, Gumà, J, Baron, B, Duran, A, Pranzo, A, Serikoff, A, Mott, D, Herdman, M, Pavesi, M, De Santis, M. 01/03/2022

    Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03).

    Gnant M, Dueck AC, Frantal S, Martin M, Burstein HJ, Greil R, Fox P, Wolff AC, Chan A, Winer EP, Pfeiler G, Miller KD, Colleoni M, Suga JM, Rubovsky G, Bliss JM, Mayer IA, Singer CF, Nowecki Z, Hahn O, Thomson J, Wolmark N, Amillano K, Rugo HS, Steger GG, Hernando Fernández de Aránguiz B, Haddad TC, Perelló A, Bellet M, Fohler H, Metzger Filho O, Jallitsch-Halper A, Solomon K, Schurmans C, Theall KP, Lu DR, Tenner K, Fesl C, DeMichele A, Mayer EL. 20/01/2022

    Amanida: an R package for meta-analysis of metabolomics non-integral data

    Llambrich, M, Correig, E, Guma, J, Brezmes, J, Cumeras, R. 15/01/2022

    Incidence of myeloid neoplasms in Spain (2002-2013): a population-based study of the Spanish network of cancer registries

    Solans, M, Sanvisens, A, Ameijide, A, Merino, S, Rojas, D, Alemán, A, Banqueri, E, Chico, M, Marcos, AI, de Castro, V, Gil, L, de Munain, AL, Puigdemont, M, Sánchez, MJ, Perucha, J, Ruiz-Armengol, P, Chirlaque, MD, Guevara, M, Carulla, M, Marcos-Gragera, R. 10/01/2022

    Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening

    Posso, M, Alcántara, R, Vázquez, I, Comerma, L, Baré, M, Louro, J, Quintana, MJ, Román, M, Marcos-Gragera, R, Vernet-Tomas, M, Saladie, F, Vidal, C, Bargalló, X, Peñalva, L, Sala, M, Castells, X. 01/01/2022

    Prospective evaluation of the prognostic value of circulating tumor DNA in patients with follicular lymphoma: A pilot study.

    Fernández-Miranda, I, Ballesteros, AK, Llanos, M, Franco, F, Martin-Acosta, P, Pedrosa, L, Arroyo, FRG, Guma, J, Carvajal, LG, Banaclocha, NM, Marin, M, Sequero, S, Gomez, S, Morera, BH, Fernández-Clemente, M, Yanguas-Casás, N, Calvo, V, Dominguez, A, Provencio, M, Sanchez-Beato, M. 01/06/2022

    Efficacy and safety of atezolizumab concurrent with radiotherapy in patients with muscle-invasive bladder cancer: An interim analysis of the ATEZOBLADDERPRESERVE phase II trial (SOGUG-2017-A-IEC(VEJ)-4).

    Vazquez-Estevez, S, Fernandez-Calvo, O, Bonfill-Abella, T, Sequero, S, Martínez-Madueño, F, Romero-Laorden, N, Domenech-Santasusana, M, Sevillano, E, Sánchez, JG, Alvarez-Fernandez, C, Núñez-González, C. 01/06/2022

    Using population-based data to evaluate the impact of adherence to endocrine therapy on survival in breast cancer through the web-application BreCanSurvPred

    Font, R, Buxó, M, Ameijide, A, Martínez, JM, Marcos-Gragera, R, Carulla, M, Puigdemont, M, Vilardell, M, Civit, S, Viñas, G, Espinàs, JA, Galceran, J, Izquierdo, A, Borràs, JM, Clèries, R. 16/05/2022

    Estimates of the incidence of hematological neoplasms in Spain, 2021: Study of the Spanish Network of Cancer Registries (REDECAN)

    Sanvisens, A, Ameijide, A, Carulla, M, Marcos-Gragera, R. 18/03/2022

    No Excess Mortality up to 10 Years in Early Stages of Breast Cancer in Women Adherent to Oral Endocrine Therapy: A Probabilistic Graphical Modeling Approach

    Clèries, R, Buxó, M, Vilardell, M, Ameijide, A, Martínez, JM, Font, R, Marcos-Gragera, R, Puigdemont, M, Viñas, G, Carulla, M, Espinàs, JA, Galceran, J, Izquierdo, A, Borràs, JM. 01/03/2022

    Predicting Ovarian-Cancer Burden in Catalonia by 2030: An Age-Period-Cohort Modelling

    Peremiquel-Trillas, P, Frias-Gomez, J, Alemany, L, Ameijide, A, Vilardell, M, Marcos-Gragera, R, Paytubi, S, Ponce, J, Martínez, JM, Pineda, M, Brunet, J, Matías-Guiu, X, Carulla, M, Galceran, J, Izquierdo, A, Borràs, JM, Costas, L, Clèries, R. 01/02/2022

  • Título: PCC03_2026_AJUDES DE L'IISPV PER AL PROJECTE CIENTIFIC COMU (PCC)_NUTRI-METLUNG, IMPACTE DE LA COMPOSICIO CORPORAL EN LA RESPOSTA I LA SUPERVIVENCIA DELS PACIENTS AMB CANCER DE PULMO NO CEL·LULA PETITA LOCALMENT AVANÇAT I METASTATIC TRACTATS AMB IMMUNOTERAPIA – IPV26002S

    Entidad financiadora: FUNDACIO INSTITUT D'INVESTIGACIO SANITARIA PERE I VIRGILI

    Duración: 2026-2027

    Investigador principal: GOZALVES , CLARA LUCIA BEATRIZ

  • Título: CONVOCATORIA D’AJUTS PER AL FOMENT DE LA CULTURA CIENTIFICA A CATALUNYA EN LA SEVA PRIMERA EDICIO 2021: LIFE FLUIDS: QUINS FLUIDS TENIM AL COS HUMA? – PV21130S

    Entidad financiadora: FUNDACIO CATALANA PER A LA RECERCA

    Duración: 2022-2022

    Investigador principal: CUMERAS OLMEDA , RAQUEL

  • Título: DTS21/00113 TITOL: TEST DE DIAGNOSTICO COLORRECTAL PARA UN CRIBADO OPTIMO DEL PACIENTE (COLOOPT DX) – PV21151S

    Entidad financiadora: INSTITUTO CARLOS III

    Duración: 2022-2023

    Investigador principal: CUMERAS OLMEDA , RAQUEL

  • Título: 2021 LLAV 00050. AJUTS D’INDUSTRIA DEL CONEIXEMENT PER A L'ANY 2021. MODALITAT A. AJUTS LLAVOR
    IONOMICA URINARIA EN LA PROGRESSIO DEL CANCER COLORECTAL – PV22088S

    Entidad financiadora: AGENCIA DE GESTIO D'AJUTS UNIVERSITARIS I DE RECERCA

    Duración: 2022-2023

    Investigador principal: CUMERAS OLMEDA , RAQUEL

  • Título: 2021 SGR 00818 GRUP DE RECERCA CONSOLIDAT (GRC) OPCIO RECONEIXEMENT SENSE FINANÇAMENT (VALIDACIO TECNICA) URV-IISPV – PV23069S

    Entidad financiadora: AGENCIA DE GESTIO D'AJUTS UNIVERSITARIS I DE RECERCA

    Duración: 2022-2025

    Investigador principal: GUMA PADRO, JOSEP

  • Título: EUROPEAN LINKAGE OF INITIATIVE FROM SCIENCE TO ACTION IN HEALTH (ELISAH) – PV23129S

    Entidad financiadora: COMMISSION OF THE EUROPEAN COMMUNITIES

    Duración: 2024-2026

    Investigador principal: GALCERAN PADROS, JAUME

  • Título: 2023 DI 00121 DOCTORATS INDUSTRIALS 2023-IDENTIFICACIO DE BIOMARCADORS DE CANCER DE PELL MITJANÇANT LA COMBINACIO DE METABOLOMICA, LIPID – PV24050S

    Entidad financiadora: AGENCIA DE GESTIO D'AJUTS UNIVERSITARIS I DE RECERCA

    Duración: 2024-2027

    Investigador principal: CUMERAS OLMEDA , RAQUEL

  • Título: 2024 PROD 00115 RAPID URINE-BASED LATERAL FLOW ASSAY FOR EARLY DETECTION OF COLORECTAL CANCER METASTASIS (METASPREAD TEST). CONVOCATORIA DELS AJUTS D’INDUSTRIA DEL CONEIXEMENT (IDC) PER A L’ANY 2024, MODALITAT B. PRODUCTE – PV24109S

    Entidad financiadora: AGENCIA DE GESTIO D'AJUTS UNIVERSITARIS I DE RECERCA

    Duración: 2024-2026

    Investigador principal: CUMERAS OLMEDA , RAQUEL

  • Título: PI24/00794 INTEGRATION OF METABOLOMICS AND GENOMICS FOR THE EARLY DIAGNOSIS OF COLORECTAL CANCER: DESING OF A
    PREDICTION TOOL (IMAGINE) – PV24126S

    Entidad financiadora: INSTITUTO CARLOS III

    Duración: 2025-2027

    Investigador principal: CUMERAS OLMEDA , RAQUEL

  • Título: FCR_1388 CONVOCATORIA D’AJUTS FCRI PER AL FOMENT DE LA CULTURA CIENTIFICA A CATALUNYA_RAQUEL CUMERAS – PV25024S

    Entidad financiadora: FUNDACIO CATALANA PER A LA RECERCA

    Duración: 2025-2025

    Investigador principal: CUMERAS OLMEDA , RAQUEL

  • Título: EU4H-2024-JA-IBA-03: IMPROVING QUALITY AND TIMELINESS OF CANCER REGISTRY DATA FEEDING INTO THE EUROPEAN CANCER INFORMATION SYSTEM (CANCERWATCH JA) – PV25061S

    Entidad financiadora: COMMISSION OF THE EUROPEAN COMMUNITIES

    Duración: 2025-2028

    Investigador principal: AMEIJIDE SÁNCHEZ, ALBERTO

  • Título: 2024 IMPAC 00055_AJUTS PER A PROJECTES PER A LA PROMOCIO DE L'IMPACTE SOCIAL DEL CONEIXEMENT DE LES UNIVERSITATS I RESTA DELS AGENTS DEL SISTEMA DE RECERCA, DESENVOLUPAMENT I INNOVACIO A CATALUNYA (IMPAC 2024)_FOMENT DE LA DETECCIO PRECOÇ DEL CANCER COLORECTAL (CRCIMPACT) – PV25125S

    Entidad financiadora: AGENCIA DE GESTIO D'AJUTS UNIVERSITARIS I DE RECERCA

    Duración: 2025-2027

    Investigador principal: CUMERAS OLMEDA , RAQUEL

  • Título: FI25/00255_CONTRATOS PREDOCTORALES DE FORMACION EN INVESTIGACION EN SALUD_PILAR CERVELLO ARAN – PV25166S

    Entidad financiadora: INSTITUTO CARLOS III

    Duración: 2026-2029

    Investigador principal: CUMERAS OLMEDA , RAQUEL

  • Título: CP25/00036 – CONTRATOS MIGUEL SERVET_RAQUEL CUMERAS OLMEDA. – PV25175S

    Entidad financiadora: INSTITUTO CARLOS III

    Duración: 2026-2030

    Investigador principal: CUMERAS OLMEDA , RAQUEL

  • Título: SOSCLC-AECC AECC 70% Survivorship Challenge -Call 2024 – PV26082S

    Entidad financiadora: FUND.INV.BIOMEDICA HOSPITAL 12 DE OCTUBRE

    Duración: 2026-2026

    Investigador principal: PERALTA MUÑOZ, SERGIO

Membres De L’equip